Identification of Neutralizing and Nonneutralizing Epitopes in the Porcine Reproductive and Respiratory Syndrome Virus GP5 Ectodomain

After infection of swine with porcine reproductive and respiratory syndrome virus (PRRSV), there is a rapid rise of PRRSV-specific nonneutralizing antibodies (NNA), while neutralizing antibodies (NA) are detectable not sooner than 3 weeks later. To characterize neutralizing epitopes, we selected phages from a 12-mer phage display library using anti-PRRSV neutralizing monoclonal antibody (MAb) ISU25-C1. In addition, phages carrying peptides recognized by swine antibodies with high seroneutralizing titer were isolated after subtracting from the library those clones binding to swine anti-PRRSV serum with no neutralizing activity. Two epitopes located in the ectodomain of PRRSV GP5 were identified. One of these epitopes, which we named epitope B, was recognized both by neutralizing MAb ISU25-C1 and swine neutralizing serum (NS) but not by swine nonneutralizing serum (NNS), indicating that it is a neutralizing epitope. Epitope B is sequential, conserved among isolates, and not immunodominant. Antibodies directed against it are detected in serum late after infection. In contrast, the other epitope, which we named epitope A, is hypervariable and immunodominant. Antibodies against it appear early after infection with PRRSV. This epitope is recognized by swine NNA but is not recognized by either neutralizing MAb ISU25-C1 or swine NA, indicating that it is not involved in PRRSV neutralization. During infection with PRRSV, epitope A may act as a decoy, eliciting most of the antibodies directed to GP5 and delaying the induction of NA against epitope B for at least 3 weeks. These results are relevant to the design of vaccines against PRRSV.

[1]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[2]  H. Nauwynck,et al.  Effect of cellular changes and onset of humoral immunity on the replication of porcine reproductive and respiratory syndrome virus in the lungs of pigs. , 2000, The Journal of general virology.

[3]  C. Gagnon,et al.  Seroneutralization of Porcine Reproductive and Respiratory Syndrome Virus Correlates with Antibody Response to the GP5 Major Envelope Glycoprotein , 1999, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[4]  Jishan Sun,et al.  Antibody repertoire development in fetal and newborn piglets, III. Colonization of the gastrointestinal tract selectively diversifies the preimmune repertoire in mucosal lymphoid tissues , 2000, Immunology.

[5]  Zongyun Chen,et al.  Detection of related positive-strand RNA virus genomes by reverse transcription/polymerase chain reaction using degenerate primers for common replicase sequences , 1995, Virus Research.

[6]  J. Meulenberg,et al.  Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus , 1997, Journal of virology.

[7]  A. Bøtner,et al.  Epitope Mapping Porcine Reproductive and Respiratory Syndrome Virus by Phage Display: the nsp2 Fragment of the Replicase Polyprotein Contains a Cluster of B-Cell Epitopes , 2001, Journal of Virology.

[8]  X. Meng,et al.  Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development , 2000, Veterinary Microbiology.

[9]  J. Christopher-Hennings,et al.  Differentiation of U.S. and European isolates of porcine reproductive and respiratory syndrome virus by monoclonal antibodies , 1993, Journal of clinical microbiology.

[10]  A. Bøtner,et al.  Examination of virus shedding in semen from vaccinated and from previously infected boars after experimental challenge with porcine reproductive and respiratory syndrome virus. , 1997, Veterinary microbiology.

[11]  J. Fominaya,et al.  Identification of an immunodominant epitope in the C terminus of glycoprotein 5 of porcine reproductive and respiratory syndrome virus. , 2001, The Journal of general virology.

[12]  A. Bøtner,et al.  Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine , 1997, Veterinary Record.

[13]  R. Vishwakarma,et al.  B Cell Responses to a Peptide Epitope. X. Epitope Selection in a Primary Response Is Thermodynamically Regulated1 , 2000, The Journal of Immunology.

[14]  S. Dea,et al.  Monoclonal antibodies to the ORF5 product of porcine reproductive and respiratory syndrome virus define linear neutralizing determinants. , 1997, The Journal of general virology.

[15]  J. Zimmerman,et al.  Categorization of North American porcine reproductive and respiratory syndrome viruses: Epitopic profiles of the N, M, GP5 and GP3 proteins and susceptibility to neutralization , 2000, Archives of Virology.

[16]  C. Gagnon,et al.  Genomic and antigenic variations of porcine reproductive and respiratory syndrome virus major envelope GP5 glycoprotein. , 1998, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[17]  A. Bøtner,et al.  Emergence of porcine reproductive and respiratory syndrome virus deletion mutants: correlation with the porcine antibody response to a hypervariable site in the ORF 3 structural glycoprotein. , 2000, Virology.

[18]  J. Zimmerman,et al.  Porcine reproductive and respiratory syndrome virus replicates in testicular germ cells, alters spermatogenesis, and induces germ cell death by apoptosis , 1997, Journal of virology.

[19]  S. Goyal,et al.  Chronological Immunohistochemical Detection and Localization of Porcine Reproductive and Respiratory Syndrome Virus in Gnotobiotic Pigs , 1996, Veterinary pathology.

[20]  D. Cavanagh.  Nidovirales: a new order comprising Coronaviridae and Arteriviridae. , 1997, Archives of virology.

[21]  F. Osorio,et al.  PRRSV: Comparison of commercial vaccines in their ability to induce protection against current PRRSV strains of high virulence , 1998 .

[22]  C. Gagnon,et al.  Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates , 2000, Archives of Virology.

[23]  F. Osorio,et al.  North American and European porcine reproductive and respiratory syndrome viruses differ in non-structural protein coding regions. , 1999, The Journal of general virology.

[24]  S. Goyal,et al.  A Modified Serum Neutralization Test for the Detection of Antibody to Porcine Reproductive and Respiratory Syndrome Virus in Swine Sera , 1994, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[25]  K. Keffaber.  Reproductive failure of unknown etiol-ogy. , 1989 .

[26]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Forsberg,et al.  Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations. , 2001, The Journal of general virology.

[28]  R. Rowland,et al.  The evolution of porcine reproductive and respiratory syndrome virus: quasispecies and emergence of a virus subpopulation during infection of pigs with VR-2332. , 1999, Virology.

[29]  R. Rowland,et al.  A 10-kDa structural protein of porcine reproductive and respiratory syndrome virus encoded by ORF2b. , 2001, Virology.

[30]  D. Ho,et al.  Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody , 1991, Journal of virology.

[31]  M H Van Regenmortel,et al.  From absolute to exquisite specificity. Reflections on the fuzzy nature of species, specificity and antigenic sites. , 1998, Journal of immunological methods.

[32]  S. Dea,et al.  Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus. , 1998, The Journal of general virology.

[33]  E. Buratti,et al.  Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response. , 2000, Virology.

[34]  P. Nakra,et al.  B cell responses to a peptide epitope , 2000 .

[35]  S. Demaret,et al.  European serotype PRRSV vaccine protects against European serotype challenge whereas an American serotype vaccine does not. , 1998, Advances in experimental medicine and biology.

[36]  Z. Chen,et al.  The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein. , 1998, Virology.

[37]  K. Conzelmann,et al.  Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4. , 1999, Veterinary microbiology.

[38]  K. Conzelmann,et al.  Molecular characterization of porcine respiratory and reproductive syndrome virus (PRRSV), a member of the arterivirus group , 1993 .

[39]  F. Osorio,et al.  Mutations in the genome of porcine reproductive and respiratory syndrome virus responsible for the attenuation phenotype , 2000, Archives of Virology.

[40]  G. Rimmelzwaan,et al.  Refocusing neutralizing antibody response by targeted dampening of an immunological epitope , 2001 .